Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

INTRODUCTION: Hyperglucagonemia is a key pathophysiological driver of type 2 diabetes. Although Roux-en-Y gastric bypass (RYGB) is a highly effective treatment for diabetes, it is presently unclear how surgery alters glucagon physiology. The aim of this study was to characterize the behavior of prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexiadou, Kleopatra, Cuenco, Joyceline, Howard, James, Wewer Albrechtsen, Nicolai Jacob, Ilesanmi, Ibiyemi, Kamocka, Anna, Tharakan, George, Behary, Preeshila, Bech, Paul R, Ahmed, Ahmed R, Purkayastha, Sanjay, Wheller, Robert, Fleuret, Matthieu, Holst, Jens Juul, Bloom, Stephen R, Khoo, Bernard, Tan, Tricia M-M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Obesity Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103850/
https://www.ncbi.nlm.nih.gov/pubmed/32209584
http://dx.doi.org/10.1136/bmjdrc-2019-001076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103850/
https://www.ncbi.nlm.nih.gov/pubmed/32209584
http://dx.doi.org/10.1136/bmjdrc-2019-001076

Ejemplares similares